The Efficacy and Safety of Y-3 Intracalvariosseous Injection Versus Intravenous Injection in the Treatment of Acute Large Hemispheric Infarction
Conditions: Stroke, Acute Ischemic; Blood-Brain Barrier Interventions: Procedure: Y-3 ICO injection; Drug: Y-3 intravenous injection; Other: Conventional treatment Sponsors: yilong Wang Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Tirofiban for Successful Endovascular Stroke Thrombectomy
Conditions: Stroke, Acute Ischemic Interventions: Drug: Intraarterial and intravenous tirofiban; Drug: Intraarterial and intravenous placebo Sponsors: Zhongming Qiu; The Second Affiliated Hospital of Chongqing Medical University; Mianyang Central Hospital; The Second Hospital of Jiaozuo; Chongzhou People ' s Hospital; Xihua People ' s Hospital; Xingguo People ' s Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA5 Device
Conditions: Acute Ischemic Stroke From Large Vessel Occlusion Interventions: Device: ANA Funnel Catheter; Device: Control Sponsors: Anaconda Biomed S.L. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Statins Role in Acute Ischemic Stroke
Conditions: Stroke, Acute Interventions: Drug: rosuvastatin Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Rescue Extracranial Vertebral Stenting in Tandem Occlusions
Conditions: Acute Stroke; Ischemic Stroke, Acute; Vertebro Basilar Ischemia Interventions: Procedure: Rescue extracrnial stenting Sponsors: Dr. Cuong Tran Chi Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
Telerehabilitation to Improve Balance and Mobility in Patients After Stroke
Conditions: Hemorrhagic Stroke; Ischemic Stroke Interventions: Behavioral: Telerehabilitation Sponsors: University Rehabilitation Institute, Republic of Slovenia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke
Conditions: Ischemic Stroke Interventions: Drug: Atorvastatin 40 Mg Oral Tablet; Drug: Rosuvastatin 20mg Sponsors: Kafrelsheikh University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Methylprednisolone Adjunctive to Endovascular Treatment for Stroke
Conditions: Acute Ischemic Stroke Interventions: Drug: Methylprednisolone Sponsors: Wan-Jin Chen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
The Prediction of Hemorrhage Transformation by Cerebral Autoregulation in AIS Patient After Endovascular Thrombectomy
Conditions: Acute Ischemic Stroke; Endovascular Thrombectomy; Dynamic Cerebral Autoregulation Interventions: Procedure: endovascular thrombectomy Sponsors: Xuanwu Hospital, Beijing Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Ischemic Postconditioning in Carotid Surgery
Conditions: Ischemic Postconditioning; Carotid Surgery; Stroke; Carotid Artery Diseases Interventions: Procedure: Ischemic postconditioning in carotid surgery; Procedure: Eversion Carotid Endarterectomy Sponsors: Institute for Cardiovascular Diseases " Dedinje " Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Minor Stroke or TIA
Conditions: Ischemic Stroke Interventions: Drug: Atorvastatin 40mg; Drug: Rosuvastatin 20mg Sponsors: Kafrelsheikh University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
Understanding Visual Processing After Occipital Stroke
Conditions: Vision Loss Partial; Vision; Loss, Both Eyes; Hemianopia, Homonymous; Hemianopia; Quadrantanopia; Stroke, Ischemic; Stroke - Occipital Infarction; Cortical Blindness; Occipital Lobe Infarct; Peripheral Visual Field Defect of Both Eyes Sponsors: University of Rochester Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials
Third Enhanced Control of Hypertension and Thrombectomy Stroke Domain Within A Multi-faCtorial, mulTi-arm, Multi-staGe, Randomised, gLOBal Adaptive pLatform Trial for Stroke
Conditions: Ischemic Stroke, Acute Interventions: Other: Conservative SBP Control; Other: Moderate SBP Control; Other: Intensive SBP Control Sponsors: The George Institute; University of Calgary; Changhai Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials
Third Enhanced Control of Hypertension and Thrombectomy Stroke Domain Within ACT-GLOBAL Adaptive Platform Trial
Conditions: Ischemic Stroke, Acute Interventions: Other: Conservative SBP Control; Other: Moderate SBP Control; Other: Intensive SBP Control Sponsors: The George Institute; University of Calgary; Changhai Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials
Effectiveness of Yangxue Qingnao Granules in Preventing Post Thrombolytic Hemorrhage Transformation in Patients With Acute Cerebral Infarction
Conditions: Stroke, Acute Ischemic Interventions: Drug: Yangxue Qingnao Granules Sponsors: Peking University Third Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials